121 related articles for article (PubMed ID: 38490332)
1. Evaluation of an enhanced depression and anxiety screening with targeted pharmacist intervention.
Reid S; Nichols R; Veach S; Alhersh E; Witry M
J Am Pharm Assoc (2003); 2024; 64(3):102067. PubMed ID: 38490332
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
Perera PN; Guy MC; Sweaney AM; Boesen KP
J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
[TBL] [Abstract][Full Text] [Related]
3. Development, implementation, and evaluation of a pharmacist-conducted screening program for depression.
Rosser S; Frede S; Conrad WF; Heaton PC
J Am Pharm Assoc (2003); 2013; 53(1):22-9. PubMed ID: 23636152
[TBL] [Abstract][Full Text] [Related]
4. An evaluation of mental health clinical pharmacist independent prescribers within general practice in remote and rural Scotland.
Buist E; McLelland R; Rushworth GF; Stewart D; Gibson-Smith K; MacLure A; Cunningham S; MacLure K
Int J Clin Pharm; 2019 Oct; 41(5):1138-1142. PubMed ID: 31493208
[TBL] [Abstract][Full Text] [Related]
5. Analysis of pharmacist-provided medication therapy management (MTM) services in community pharmacies over 7 years.
Barnett MJ; Frank J; Wehring H; Newland B; VonMuenster S; Kumbera P; Halterman T; Perry PJ
J Manag Care Pharm; 2009; 15(1):18-31. PubMed ID: 19125547
[TBL] [Abstract][Full Text] [Related]
6. Utility of a brief screening tool for medication-related problems.
Snyder ME; Pater KS; Frail CK; Hudmon KS; Doebbeling BN; Smith RB
Res Social Adm Pharm; 2015; 11(2):253-64. PubMed ID: 25443640
[TBL] [Abstract][Full Text] [Related]
7. Inpatient pharmacists' patient referrals to a transitions-of-care pharmacist: Evaluation of an automated referral process.
Kerstenetzky L; Heimerl KM; Hartkopf KJ; Hager DR
J Am Pharm Assoc (2003); 2018; 58(5):540-546. PubMed ID: 30017369
[TBL] [Abstract][Full Text] [Related]
8. A feasibility study of community pharmacists performing depression screening services.
O'Reilly CL; Wong E; Chen TF
Res Social Adm Pharm; 2015; 11(3):364-81. PubMed ID: 25438728
[TBL] [Abstract][Full Text] [Related]
9. Depression screening in adults by pharmacists in the community: a systematic review.
Miller P; Newby D; Walkom E; Schneider J; Li SC
Int J Pharm Pract; 2020 Oct; 28(5):428-440. PubMed ID: 32776433
[TBL] [Abstract][Full Text] [Related]
10. Pharmacist-led depression screening and intervention in an underserved, rural, and multi-ethnic diabetic population.
Wilson C; Twigg G
J Am Pharm Assoc (2003); 2018; 58(2):205-209. PubMed ID: 29217142
[TBL] [Abstract][Full Text] [Related]
11. Patient attitudes regarding pharmacist-administered memory screening in community pharmacies.
Breslow RM
J Am Pharm Assoc (2003); 2013; 53(6):648-51. PubMed ID: 24185433
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.
Hirsch JD; Rosenquist A; Best BM; Miller TA; Gilmer TP
J Manag Care Pharm; 2009; 15(1):32-41. PubMed ID: 19125548
[TBL] [Abstract][Full Text] [Related]
13. Involving the public and other stakeholders in development and evaluation of a community pharmacy alcohol screening and brief advice service.
Krska J; Mackridge AJ
Public Health; 2014 Apr; 128(4):309-16. PubMed ID: 24713598
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
[TBL] [Abstract][Full Text] [Related]
15. Pharmacist consultations in general practice clinics: the Pharmacists in Practice Study (PIPS).
Tan EC; Stewart K; Elliott RA; George J
Res Social Adm Pharm; 2014; 10(4):623-32. PubMed ID: 24095088
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular disease risk screening by pharmacists: a behavior change wheel guided qualitative analysis.
Almansour HA; Mekonnen AB; Aloudah NM; Alhawassi TM; Mc Namara K; Chaar B; Krass I; Saini B
Res Social Adm Pharm; 2020 Feb; 16(2):149-159. PubMed ID: 31027964
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
Wibowo Y; Parsons R; Sunderland B; Hughes J
Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
[TBL] [Abstract][Full Text] [Related]
18. How pharmacists check the appropriateness of drug therapy? Observations in community pharmacy.
Nusair MB; Guirguis LM
Res Social Adm Pharm; 2017; 13(2):349-357. PubMed ID: 27102265
[TBL] [Abstract][Full Text] [Related]
19. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
Isho NY; Kachlic MD; Marcelo JC; Martin MT
J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379
[TBL] [Abstract][Full Text] [Related]
20. Exploring pharmacy service users' support for and willingness to use community pharmacist prescribing services.
Famiyeh IM; MacKeigan L; Thompson A; Kuluski K; McCarthy LM
Res Social Adm Pharm; 2019 May; 15(5):575-583. PubMed ID: 30100199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
